Suppr超能文献

MRI 垂体成像及其在评估低促性腺激素性性腺功能减退症男性患者中的生化参数相关性。

PITUITARY IMAGING BY MRI AND ITS CORRELATION WITH BIOCHEMICAL PARAMETERS IN THE EVALUATION OF MEN WITH HYPOGONADOTROPIC HYPOGONADISM.

出版信息

Endocr Pract. 2019 Sep;25(9):926-934. doi: 10.4158/EP-2018-0609. Epub 2019 Jun 6.

Abstract

A significant ambiguity still remains about which patient deserves a magnetic resonance imaging (MRI) scan of the pituitary during evaluation of hypogonadotropic hypogonadism (HH) in men. Retrospective case series of 175 men with HH referred over 6 years. A total of 49.7% of men had total testosterone (TT) levels lower than the Endocrine Society threshold of 5.2 nmol/L. One-hundred forty-two patients (81.2%) had normal appearance of pituitary MRI, whereas others had different spectrum of abnormalities (empty sella [n = 16], macroadenoma [n = 8], microadenoma [n = 8], and pituitary cyst [n = 1]). In men with TT in the lowest quartile, MRI pituitary findings were not significantly different from men in the remaining quartiles ( = .50). Patients with raised prolactin had higher number of abnormal MRI findings (38.9% vs. 13.7%; = .0014) and adenomatous lesions (macro and micro) (27.8% vs. 4.3%; = .01) in comparison to men with normal prolactin. The prolactin levels (median [interquartile range]) were highest in men with macroadenomas in both groups (9,950 [915]; = .007 and 300 [68.0] mU/L; = .02, respectively), with concomitant lower levels of other pituitary hormones. Multivariate logistic regression showed an association of abnormal pituitary MRI with insulin-like growth factor 1 (IGF-1) standard deviation score (SDS) (odds ratio [OR], 1.78 [95% confidence interval (CI), 1.15 to 2.77]; = .009) and prolactin (OR, 1.00 [95% CI, 1.00 to 1.03]; = .01). MRI of the pituitary is not warranted in all patients with HH, as the yield of identifiable abnormalities is quite low. Anatomic lesions are likely to be present only when low levels of TT (<5.2 nmol/L) are found concomitantly with high levels of prolactin and/or low IGF-1 SDS. = confidence interval; = free thyroxine; = growth hormone; = hypogonadotropic hypogonadism; = insulin-like growth factor; = luteinizing hormone; = magnetic resonance imaging; = odds ratio; = standard deviation score; = thyroid-stimulating hormone; = total testosterone.

摘要

在评估男性低促性腺激素性性腺功能减退症(HH)时,对于哪些患者需要进行垂体磁共振成像(MRI)检查,仍然存在很大的不确定性。

这是一项回顾性病例系列研究,纳入了 6 年内就诊的 175 名 HH 男性患者。共有 49.7%的男性总睾酮(TT)水平低于内分泌学会规定的 5.2 nmol/L 阈值。142 名患者(81.2%)的垂体 MRI 表现正常,而其他患者则存在不同谱的异常(空蝶鞍[n=16]、大腺瘤[n=8]、微腺瘤[n=8]和垂体囊肿[n=1])。在 TT 处于最低四分位数的男性中,MRI 垂体发现与剩余四分位的男性无显著差异(=0.50)。催乳素升高的患者异常 MRI 发现的数量更高(38.9%比 13.7%;=0.0014),且腺性病变(大腺瘤和微腺瘤)(27.8%比 4.3%;=0.01)更多。两组中,催乳素水平最高的是大腺瘤患者(均为 9950 [915];=0.007 和 300 [68.0] mU/L;=0.02),同时其他垂体激素水平较低。多变量逻辑回归显示,异常垂体 MRI 与胰岛素样生长因子 1(IGF-1)标准差评分(SDS)(比值比[OR],1.78 [95%置信区间(CI),1.15 至 2.77];=0.009)和催乳素(OR,1.00 [95%CI,1.00 至 1.03];=0.01)有关。并非所有 HH 患者都需要进行垂体 MRI,因为可识别异常的检出率相当低。只有当 TT(<5.2 nmol/L)水平低的同时伴有催乳素水平高和/或 IGF-1 SDS 低时,才可能出现解剖学病变。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验